$599

Tandem Acquires Capillary Biomedical; Lilly’s Mounjaro Receives Positive CHMP Opinion

Two cardiometabolic-related news items have been observed: Tandem announced it has acquired Capillary Biomedical; and EMA announced Mounjaro (tirzepatide) received a positive CHMP opinion for the treatment of T2DM in adults. Below, FENIX provides highlights and insights for the respective new items.

This content is for Read Less members only.
Already a member? Log in here